ITA 7th Edition Life Sciences Acceleration | Matchmaking Sprint 1 with VCs by Elpis Labs
Ten Italian life sciences startups. Dedicated 1:1 slots, matched to your thesis.
This is the first installment of the ITA 7th Edition Life Sciences Accelerator's targeted matching events, focused on VCs and institutional investors.
Not an open-floor mixer: we pre-map each fund's therapeutic, diagnostic and digital-health mandate against the cohort's technical profiles, then book the meetings that fit.
Every founder arrives having already worked through U.S. entity structuring, IP protection and their FDA pathway.
WHY TAKE THESE MEETINGS
Differentiated deal flow — European science that hasn't been shopped around the U.S. market yet
A cohort pre-screened by the Italian Trade Agency and diligence-prepped by Elpis Labs
Seed to Series A/B, spanning MedTech, Biotech, Pharma and Digital Health
Data rooms already built and validated; you get materials before the meeting, not after
Founders committing to a U.S. presence, not testing the idea
THE COHORT — 10 ITALIAN COMPANIES, SEED TO SERIES A/B
Biotech & Pharma:
— Kiran Biotech (AvidinOX® platform delivering radiotherapeutics directly to inoperable tumors)
— THERA65 (aptamer-based PROTAC degrading p65BTK to break drug resistance in solid tumors)
— BrightMol Biotech (Univ. of Trento spin-off; LIPS fluorescent target validation, 4× faster and 50% cheaper)
Digital Health & MedTech
— Nemira (privacy-first ambient AI monitoring for older adults with memory disorders, no wearables)
— Ninacare (AI workforce platform for care homes and private hospitals)
— V-Apps.cloud (QHSE+ compliance, quality and safety SaaS with patented AI automation)
— QubiTale (privacy-first AI platform unlocking healthcare insights without moving or exposing confidential records)
Life-science adjacent:
— Alma Serum (dairy-waste nanotech turned into high-performance skincare)
— Mariscadoras / Blueat (zero-waste startup transforming invasive blue crabs into food and eco-friendly biomaterials)
— AlphaFood (alternative-protein nutrition on a patented vertical insect-farming system)
Five of the ten are female-founded. 🇮🇹
HOW IT WORKS
Register and tell us your thesis — stage, vertical, check size
We match against the cohort's technical profiles and send you a personal schedule with company one-pagers in advance
Dedicated 15–30 minute 1:1 matching slots, back to back, on site
Your Elpis Scale Manager contact logs follow-ups the same day and handles next steps
WHO SHOULD REGISTER
Life sciences, medtech and digital health VCs
Seed and Series A/B funds with cross-border or European mandates
Corporate venture teams with a West Coast footprint
Family offices and institutional allocators with healthcare mandates
ABOUT THE PROGRAM
The ITA Life Sciences Accelerator is an intensive 6-week program supporting a curated cohort of 10 high-growth Italian life sciences startups: 2 weeks online, 3 weeks on-site in San Diego and 1 week in Boston, connecting founders directly with US market expertise.
Delivered by Elpis Labs with the e Italian Trade Agency. Founders work through U.S. entity and IP structuring, FDA pathways, payer and hospital procurement, GTM localization and capital strategy, supported by matched Ph.D. and MBA interns from regional universities.
📩 Questions, referrals and partner slots: info@elpislabs.vc or ken@elpislabs.vc
Capacity is limited — slots are allocated in order of confirmed thesis fit.
ABOUT ELPIS LABS
Elpis Labs is a corporate innovation and U.S. market-access firm connecting corporations, startups, investors, and public-sector organizations across global innovation ecosystems.
We help corporations discover emerging technologies, scout high-potential startups, and design pilot and innovation programs. For international startups and public-sector partners, we build accelerator, soft-landing, trade-mission, and market-entry programs that create practical pathways into the U.S. market.
🔗 elpislabs.com · New York corporate innovation & U.S. market entry · Industries we work with · Contact Elpis Labs